A Risk Sciences International news item posted on April 26, 2022 and last updated on September 9, 2025

Following previous work on the potential risk of acute liver failure associated with quinolone antibiotics, RSI investigators, Mohamed Taher, Franco Momoli, Donald Mattison and Daniel Krewski evaluated the potential risk of retinal detachment (RD) associated with these medications.

Although no cases of RD were linked to quinolones in clinical trials, some reports of RD were noted in the US FDA Adverse Event Reporting System in conjunction with systemic use of quinolone antibiotics. Analysis of electronic health records from over 500 US healthcare institutions revealed elevated but non-significant risks in African Americans (ciprofloxacin and levofloxacin), those aged 56–70 years old (moxifloxacin), and women (ciprofloxacin).

The authors noted that these suggestions of increased risk observed in some population subgroups warrant further investigation.

Quinolones
Quinolones

Experts related to this news item

Franco Momoli

Vice-President Chemical and Product Safety

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments...
Read More about Franco Momoli

Donald Mattison (1944-2026)

Chief Medical Officer, Senior Vice-President

In Memoriam: Dr. Donald Mattison (1944-2026) Dr. Donald Mattison passed away at his home in Columbia, South Carolina on Sunday, March 22, with his family present. Don joined Risk Sciences International (RSI) in 2012 as Vice President and Chief Medical...
Read More about Donald Mattison (1944-2026)

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski

More RSI News

In Memoriam: Dr. Donald Mattison (1944-2026)

March 27, 2026

In Memoriam: Dr. Donald Mattison (1944-2026)

Dr. Donald Mattison passed away at his home in Columbia, South Carolina on Sunday, March 22, with his family present.

Don joined Risk Sciences International (RSI) in 2012 as Vice President and Chief Medical Officer, following a distinguished career spanning government, academia, and clinical practice in the United States. During his time at RSI, he contributed to 47 scientific publications and served as a trusted mentor and colleague to many across the organization.

RSI CEO Greg Paoli Named Fellow of the Society for Risk Analysis

January 12, 2026

Risk Sciences International (RSI) is proud to announce that CEO Greg Paoli has been designated as a Fellow of the Society for Risk Analysis (SRA).…

Bias Assessment in Case-Control and Cohort Studies for Hazard Identification

November 4, 2025

IARC recently published a volume on quantitative bias modelling: Bias assessment in case–control and cohort studies for hazard identification (IARC Scientific Publication No. 171). We…

RSI Helps Strengthen Food Safety Culture in Vietnam

October 21, 2025

In mid-October 2025, Vietnamese and Canadian experts convened in Đà Nẵng to exchange approaches for strengthening food safety through risk science. The workshop brought together…